Why Is IMI Up Today?

IMI plc (LSE:IMI) shares rose 0.07% to 2,938.0p today, a gain of 2.0p on the session. The engineering group remains in focus following half-year results that included higher revenue, rising profit and an increased interim dividend.

For the six months to June 2026, Revenue rose 6% to £1.16 billion, with organic growth of 5%, and adjusted operating profit increased 10% to £217 million.

About IMI plc

IMI plc is a specialist engineering group focused on motion and fluid control technologies. Its products include precision valves, actuators, pneumatic systems and fluid control components used in industrial automation, life sciences, energy, transport and food and beverage applications.

LSE:IMI has a 0.27% weighting in the FTSE 100 and a Market Capitalisation of about £6.9 billion. The group operates through two divisions, Automation and Life Technology.

Half-Year Financial Performance

Revenue of £1.16 billion compared with £1.09 billion a year earlier. Adjusted operating profit of £217 million was up from £198 million, a rise of 10%, or 8% on an organic basis.

Operating profit rose 27% to £201 million, and adjusted Basic Earnings Per Share increased 13% to 63.4p from 56.1p. Basic earnings per share rose 26% to 57.7p.

Divisional Performance

Automation revenue was £732 million, up 6% from £691 million, with organic growth of 5%. The division supplies products that help customers automate factories and processes, including pneumatic and motion control technology.

Life Technology revenue was £427 million, up 7% from £400 million, with organic growth of 5%. This division includes products for medical, laboratory and diagnostic equipment, as well as transport and food applications.

Interim Dividend

The Interim Dividend was increased 10% to 12.1p per share from 11.0p. The increase reflects the group's cash generation and its progressive approach to Shareholder returns.

Outlook

Management confirmed its guidance for 2026, with adjusted basic earnings per share expected in the range of 136p to 142p. The group remains on track for a sixth consecutive year of mid-single-digit organic revenue growth.

Why Engineering Specialisation Matters

IMI's products are often specified into customers' machines and processes, so performance and reliability are critical. Close technical relationships and application knowledge help the group win Business and defend its positions over many years.

Automation is a Long-term Growth theme, as manufacturers look to improve productivity, quality and energy efficiency. Similarly, life sciences customers rely on precise fluid handling in analyser and diagnostic equipment.

Operations and Innovation

The group invests in engineering talent and in new product development, and it uses a lean operating approach to improve efficiency across its sites. Portfolio Management has also been a feature, with the company focusing Investment on areas with attractive growth and returns.

Sustainability

IMI has set targets to reduce its own emissions and develops products that help customers use less energy and waste less material. Energy-efficient pneumatic and valve technology supports customers' own decarbonisation goals.

Automation Applications

The Automation division supplies pneumatic, fluid control and motion technologies used in factory automation, packaging machinery, food and beverage processing and energy applications. Customers rely on these components to move, position and control products accurately and at high speed, and reliability is critical because downtime can be costly.

Many of these products are specified early in the design of a machine and then supplied for the life of the equipment, which creates a base of repeat demand. Close collaboration between IMI engineers and customer design teams helps the group tailor solutions to specific applications.

Life Technology Applications

Life Technology focuses on precision fluid control for medical, laboratory and diagnostic equipment, as well as on products for transport and industrial gases. Instruments such as analysers, ventilators and drug delivery devices require components that perform reliably and meet demanding standards.

Healthcare spending, an ageing population and growth in diagnostic testing support long-term Demand in these markets. Close relationships with equipment manufacturers help the division secure positions on new platforms that can last for many years.

Factors to Monitor

Investors following LSE:IMI may watch organic growth in each division, order trends in automation, Margin progress, cash generation and delivery against the 2026 earnings guidance.

Conclusion

IMI plc rose 0.07% to 2,938.0p today following half-year results showing 6% revenue growth, a 10% increase in adjusted operating profit and a 10% higher interim dividend. Specialist engineering and steady organic growth remain central themes. Future company announcements should provide further detail on operating progress, capital allocation and management priorities.